iAssay, Inc.

iAssay, Inc. offers a comprehensive Point of Care Testing and Health IT Solution aimed at revolutionizing the healthcare industry. Founded in 2013 and headquartered in the United States, iAssay's innovative technology consolidates and replaces all existing test devices with a single, handheld solution. This groundbreaking approach eliminates the need for multiple daily trips to central labs, enabling testing at the patient's location and delivering results in minutes, thereby eliminating delays in diagnosis. Furthermore, the system is designed to aggregate and securely transmit data to the cloud for seamless integration into patients' electronic medical records. The company is actively seeking Dx Content Partners and investors, with its last investment being a Seed Round in May 31, 2017 led by WS Investments. With a primary focus on the intersection of Health Care and IT, iAssay's unique position as the world's only handheld device for point of care diagnostics, integrated with numerous apps and adaptable plug-ins, demonstrates its potential to streamline healthcare processes and improve patient outcomes while reducing costs. For more information and to explore partnership opportunities, visit www.iassay.net.